Pediatric COVID-19 Therapeutics: Seizing the Right Research and Development Opportunities to Accelerate Access for Children

Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/73248

Title:	Pediatric COVID-19 Therapeutics: Seizing the Right Research and Development Opportunities to Accelerate Access for Children
Authors:	Sébastien Morin Marc Lallemant Anthony Garcia-Prats Linda Lewis Melynda Watkins Carlo Giaquinto Marie Valentin Martina Penazzato John C. Reeder
Authors:	Sébastien Morin Marc Lallemant Anthony Garcia-Prats Linda Lewis Melynda Watkins Carlo Giaquinto Marie Valentin Martina Penazzato John C. Reeder
Keywords:	Medicine
Issue Date:	1-Jan-2022
Abstract:	Children, although at lower risk of poor outcomes from COVID-19 relative to adults, still stand to benefit from therapeutic interventions. Understanding of COVID-19 clinical presentation and prognosis in children is essential to optimize therapeutic trials design. This perspective illustrates how to collectively accelerate pediatric COVID-19 therapeutic research and development, based on the experience of the Global Accelerator for Paediatric Formulations.
URI:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85122016524&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/73248
ISSN:	15320987 08913668
Appears in Collections:	CMUL: Journal Articles

Files in This Item:

There are no files associated with this item.